Latest Issue

Volume 2 Issue 2

Paper of the Month

Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized Phase III trial.

Sternberg CN, Davis ID, Mardiak J et al.
Pazopanib is an oral angiogenesis inhibitor that targets vascular endothelial growth factor receptor, platelet-derived growth factor, and c-Kit.
» Read an expert review of this paper

Webcast

Our most popular articles

Latest news

  • Home
  • Home
  • Home
  • Home
  • Home
  • Home
CLOSE
Your First Name

Your Surname

Recipient's Email Address *

To automatically send an email containing a link to this page, please enter the recipient's email address and your name (optional).

READER SURVEY

SUBMIT AN ARTICLE

OTHER REMEDICA JOURNALS

COMPASS PUBMED SEARCH

Enter your search terms below to search pubmed for articles